High percentage of resistance to ciprofloxacin and qnrB19 gene identified in urinary isolates of extended-spectrum β-lactamase-producing Escherichia coli in Madrid, Spain

Diagnostic Microbiology and Infectious Disease

Volumn 67, Issue 4, 2010, Pages 380-383

  Ríos, Esther ^a   Rodríguez Avial, Iciar ^a   Rodríguez Avial, Carmen ^a   Hernandez, Elena ^a   Picazo, Juan Jose ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

E. coli; Fluoroquinolone; Qnr; Resistance

Indexed keywords

BACTERIAL PROTEIN; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; LEVOFLOXACIN; PROTEIN PARC; PROTEIN QNR; PROTEIN QNRA; PROTEIN QNRB; PROTEIN QNRB19; PROTEIN QNRS; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BETA LACTAMASE; DNA TOPOISOMERASE IV; ESCHERICHIA COLI PROTEIN;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; CASE REPORT; CONJUGATION; DNA SEQUENCE; ESCHERICHIA COLI; GENE MUTATION; GENETIC IDENTIFICATION; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPAIN; URINALYSIS; BACTERIAL GENE; BACTERIUM CONJUGATION; BIOSYNTHESIS; DRUG EFFECTS; ENZYMOLOGY; ESCHERICHIA COLI INFECTION; GENETICS; GENOTYPE; HORIZONTAL GENE TRANSFER; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CIPROFLOXACIN; CONJUGATION, GENETIC; DNA TOPOISOMERASE IV; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; GENE TRANSFER, HORIZONTAL; GENES, BACTERIAL; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; SPAIN; URINARY TRACT INFECTIONS;

EID: 77954744680     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.03.007     Document Type: Article

References (33)

1. Cattoir V., Poirel L., Rotimi V., Soussy C.J., Nordmann P. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J. Antimicrob. Chemother. 2007, 60:394-397.
2. Cattoir V., Nordmann P., Silva-Sanchez J., Espinal P., Poirel L. ISEcp1-mediated transposition of qnrB-like gene in Escherichia coli. Antimicrob. Agents Chemother. 2008, 52:2929-2932.
3. Chen F.J., Lo H.J. Molecular mechanisms of fluoroquinolone resistance. J. Microbiol. Immunol. Infect. 2003, 36:1-9.
4. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing: 17th informational supplement (M100-S17) 2007, CLSI, Wayne, PA.
5. Coque T.M., Oliver A., Pérez-Díaz J.C., Baquero F., Cantón R. Genes encoding TEM-4, SHV-2, and CTX-M-10 extended-spectrum beta-lactamases are carried by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989 to 2000). Antimicrob. Agents Chemother. 2002, 46:500-510.
6. Crémet L., Caroff N., Dauvergne S., Reynaud A., Lepelletier D., Corvec S. Prevalence of plasmid-mediated quinolone resistance determinants in ESBL Enterobacteriaceae clinical isolates over a 1-year period in a French hospital. Pathol. Biol 2009, Available May 29, 2009 (in Press).
7. de Cueto M., Hernández J.R., López-Cerero L., Morillo C., Pascual A. Activity of fosfomycin against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae. Enferm. Infecc. Microbiol. Clin. 2006, 24:613-616.
8. Fang H., Huang H., Shi Y., Hedin G., Nord C.E., Ullberg M. Prevalence of qnr determinants among extended-spectrum beta-lactamase-positive Enterobacteriaceae clinical isolates in southern Stockholm, Sweden. J. Antimicrob. Agents 2009, 34:268-270.
9. Gerhardt P., Murray R.G.E., Wood W.A., Krieg N.R. Gene transfer in gram-negative bacteria. Method for general and molecular bacteriology 1981, 317-347. American Society for Microbiology, Washington, DC. D.L. Provence, R. Curtiss (Eds.).
10. Hernández J.R., Martínez-Martínez L., Cantón R., Coque T.M., Pascual A. Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases in Spain. Antimicrob. Agents Chemother. 2005, 49:2122-2125. Spanish Group for Nosocomial Infections (GEIH).
11. Jacoby G.A., Walsh K.E., Mills D.M., Walker V.J., Oh H., Robicsek A., Hooper D.C. qnrB, another plasmid-mediated gene for quinolone resistance. Antimicrob. Agents Chemother. 2006, 50:1178-1182.
12. Jacoby G., Cattoir V., Hooper D., Martínez-Martínez L., Nordmann P., Pascual A., Poirel L., Wang M. qnr Gene nomenclature. Antimicrob Agents Chemother 2008, 52:2297-2299.
13. Kim H.B., Park C.H., Kim C.J., Kim E.C., Jacoby G.A., Hooper D.C. Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob. Agents Chemother. 2009, 53:639-645.
14. Lavigne J.P., Bouziges N., Chanal C., Mahamat A., Michaux-Charachon S., Sotto A. Molecular epidemiology of Enterobacteriaceae isolates producing extended-spectrum beta-lactamases in a French hospital. J. Clin. Microbiol. 2004, 42:3805-3808.
15. Lavilla S., González-López J.J., Sabaté M., García-Fernández A., Larrosa M.N., Bartolomé R.M., et al. Prevalence of qnr genes among extended-spectrum beta-lactamase-producing enterobacterial isolates in Barcelona, Spain. J. Antimicrob. Chemother. 2008, 61:291-295.
16. Lindgren P.K., Karlsson Å., Hughes D. Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections. Antimicrob. Agents Chemother. 2003, 47:3222-3232.
17. Mammeri H., Van De Loo M., Poirel L., Martinez-Martinez L., Nordmann P. Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe. Antimicrob. Agents Chemother. 2005, 49:71-76.
18. Martínez-Martínez L. Asociación de BLEE con otros mecanismos de resistencia. Enferm. Infecc. Microbiol. Clin. 2007, 25:38-47.
19. Martinez-Martinez L., Pascual A., Jacoby G.A. Quinolone resistance from a transferable plasmid. Lancet 1998, 351:797-799.
20. McDonald L.C., Chen F.J., Lo H.J., Yin H.C., Lu P.L., Huang C.H., et al. Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures. Antimicrob. Agents Chemother. 2001, 45:3084-3091.
21. Morgan-Linnell S.K., Zechiedrich L. Contributions of the combined effects of topoisomerase mutations toward fluoroquinolone resistance in Escherichia coli. Antimicrob. Agents Chemother. 2007, 51:4205-4208.
22. Mugnaioli C., Luzzaro F., De Luca F., Brigante G., Perilli M., Amicosante G., et al. CTX-M-type extended-spectrum beta-lactamases in Italy: molecular epidemiology of an emerging countrywide problem. Antimicrob. Agents Chemother. 2006, 50:2700-2706.
23. Pallecchi L., Riccobono E., Mantella A., Bartalesi F., Sennati S., Gamboa H., et al. High prevalence of qnr genes in commensal enterobacteria from healthy children in Peru and Bolivia. Antimicrob. Agents Chemother. 2009, 53:2632-2635.
24. Poirel L., Leviandier C., Nordmann P. Prevalence and genetic analysis of plasmid-mediated quinolone resistance determinants QnrA and QnrS in Enterobacteriaceae isolates from a French university hospital. Antimicrob. Agents Chemother. 2006, 50:3992-3997.
25. Poirel L., Pitout J.D., Calvo L., Rodriguez-Martinez J.M., Church D., Nordmann P. In vivo selection of fluoroquinolone-resistant Escherichia coli isolates expressing plasmid-mediated quinolone resistance and expanded-spectrum beta-lactamase. Antimicrob. Agents Chemother. 2006, 50:1525-1527.
26. Poirel L., Cattoir V., Nordmann P. Is plasmid-mediated quinolone resistance a clinically significant problem?. Clin. Microbiol. Infect. 2008, 14:295-297.
27. Rice L.B., Carias L.L., Hutton R.A., Rudin S.D., Endimiani A., Bonomo R.A. The KQ element, a complex genetic region conferring transferable resistance to carbapenems, aminoglycosides, and fluoroquinolones in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 2008, 52:3427-3429.
28. Robicsek A., Jacoby G.A., Hooper D.C. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect. Dis. 2006, 6:629-640.
29. Robicsek A., Strahilevitz J., Sahm D.F., Jacoby G.A., Hooper D.C. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob. Agents Chemother. 2006, 50:2872-2874.
30. Rodríguez-Martínez J.M. Mecanismos de resistencia a quinolonas mediada por plásmidos. Enferm. Infecc. Microbiol. Clin. 2005, 23:25-31.
31. Rodríguez-Martínez J.M., Velasco C., García I., Cano M.E., Martínez-Martínez L., Pascual A. Mutant prevention concentrations of fluoroquinolones for Enterobacteriaceae expressing the plasmid-carried quinolone resistance determinant qnrA1. Antimicrob. Agents Chemother. 2007, 51:2236-2239.
32. Schwaber M.J., Navon-Venezia S., Schwartz D., Carmeli Y. High levels of antimicrobial coresistance among extended-spectrum-beta-lactamase-producing Enterobacteriaceae. Antimicrob. Agents Chemother. 2005, 49:2137-2139.
33. Wang M., Tran J.H., Jacoby G.A., Zhang Y., Wang F., Hooper D.C. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob. Agents Chemother. 2003, 47:2242-2248.